Sarah Chen, MD
Endocrinologist · Medical Reviewer
Sarah Chen, MD is a board-certified endocrinologist with 14 years of clinical and research experience in metabolic disorders and hormonal therapeutics. She completed her fellowship in Endocrinology, Diabetes, and Metabolism at Johns Hopkins Hospital following residency training in internal medicine at UCSF Medical Center.
Her clinical and research work spans GLP receptor agonist pharmacology, next-generation peptide therapeutics, and the emerging biology of dual and triple agonist compounds targeting GLP-1, GIP, and glucagon receptors. She has closely followed the clinical literature on GLP-3 receptor-targeted compounds as the field has developed.
As medical reviewer for GLP3RT Notes, Dr. Chen evaluates the site's educational articles for pharmacological accuracy, appropriate representation of investigational compound status, and alignment with current clinical evidence on receptor-selective peptide research.
Training & Credentials
- MD — University of California San Francisco (UCSF) School of Medicine
- Residency, Internal Medicine — UCSF Medical Center
- Fellowship, Endocrinology, Diabetes & Metabolism — Johns Hopkins Hospital
- Board-certified, American Board of Internal Medicine (Endocrinology subspecialty)
Areas of Expertise
Dr. Chen reviews GLP3RT Notes content for accuracy in describing GLP receptor mechanisms, investigational context for compounds like retatrutide, and alignment with current pharmacological and clinical evidence.